137 related articles for article (PubMed ID: 3753579)
1. RSU 1069, a nitroimidazole containing an aziridine group. Bioreduction greatly increases cytotoxicity under hypoxic conditions.
Stratford IJ; O'Neill P; Sheldon PW; Silver AR; Walling JM; Adams GE
Biochem Pharmacol; 1986 Jan; 35(1):105-9. PubMed ID: 3753579
[No Abstract] [Full Text] [Related]
2. The differential cytotoxicity of RSU 1069: cell survival studies indicating interaction with DNA as a possible mode of action.
Stratford IJ; Walling JM; Silver AR
Br J Cancer; 1986 Mar; 53(3):339-44. PubMed ID: 3754453
[TBL] [Abstract][Full Text] [Related]
3. Analogues of RSU-1069: radiosensitization and toxicity in vitro and in vivo.
Ahmed I; Jenkins TC; Walling JM; Stratford IJ; Sheldon PW; Adams GE; Fielden EM
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1079-81. PubMed ID: 3755711
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of DNA damage in mammalian cells upon bioreduction of the nitroimidazole-aziridines RSU-1069 and RSU-1131.
Jenner TJ; Sapora O; O'Neill P; Fielden EM
Biochem Pharmacol; 1988 Oct; 37(20):3837-42. PubMed ID: 3190731
[TBL] [Abstract][Full Text] [Related]
5. Metabolism and radiosensitization of 4,5-dimethylmisonidazole, a ring-substituted analog of misonidazole.
Born JL; Smith BR; Harper N; Koch CJ
Biochem Pharmacol; 1992 Mar; 43(6):1337-44. PubMed ID: 1562284
[TBL] [Abstract][Full Text] [Related]
6. Induction of mutations in V79-4 mammalian cells under hypoxic and aerobic conditions by the cytotoxic 2-nitroimidazole-aziridines, RSU-1069 and RSU-1131. The influence of cellular glutathione.
Sapora O; Paone A; Maggi A; Jenner TJ; O'Neill P
Biochem Pharmacol; 1992 Oct; 44(7):1341-7. PubMed ID: 1417957
[TBL] [Abstract][Full Text] [Related]
7. Studies on the mechanisms of the radiosensitizing and cytotoxic properties of RSU-1069 and its analogues.
Walling JM; Stratford IJ; Adams GE; Silver AR; Ahmed I; Jenkins TC; Fielden EM
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1083-6. PubMed ID: 3755712
[TBL] [Abstract][Full Text] [Related]
8. Induction of DNA strand breaks by RSU-1069, a nitroimidazole-aziridine radiosensitizer. Role of binding of both unreduced and radiation-reduced forms to DNA, in vitro.
Silver AR; O'Neill P; Jenkins TC
Biochem Pharmacol; 1985 Oct; 34(19):3537-42. PubMed ID: 3902026
[TBL] [Abstract][Full Text] [Related]
9. Comparative DNA damage induced by nitroimidazole-aziridine drugs: 1. Effects of methyl substitution on drug action.
Dale LD; Tocher JH; Edwards DI
Anticancer Drug Des; 1988 Dec; 3(3):169-75. PubMed ID: 3207464
[TBL] [Abstract][Full Text] [Related]
10. Studies on the toxicity of RSU-1069.
Whitmore GF; Gulyas S
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1219-22. PubMed ID: 3755716
[TBL] [Abstract][Full Text] [Related]
11. The repair of DNA damage induced in V79 mammalian cells by the nitroimidazole-aziridine, RSU-1069. Implications for radiosensitization.
Jenner TJ; O'Neill P; Crump PW; Fielden EM; Sapora O; Santodonato L
Biochem Pharmacol; 1991 Oct; 42(9):1705-10. PubMed ID: 1930296
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of an (iodovinyl)misonidazole derivative for hypoxia imaging.
Biskupiak JE; Grierson JR; Rasey JS; Martin GV; Krohn KA
J Med Chem; 1991 Jul; 34(7):2165-8. PubMed ID: 2066990
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the repair and damage of DNA induced by parent and reduced RSU-1069, a 2-nitroimidazole-aziridine.
O'Neill P; Cunniffe SM
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):963-6. PubMed ID: 2649467
[TBL] [Abstract][Full Text] [Related]
14. RSU 1069, a 2-nitroimidazole containing an alkylating group: high efficiency as a radio- and chemosensitizer in vitro and in vivo.
Adams GE; Ahmed I; Sheldon PW; Stratford IJ
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1653-6. PubMed ID: 6548211
[TBL] [Abstract][Full Text] [Related]
15. In vitro assessment of the oncogenic potential of nitroimidazole radiosensitizers.
Hei TK; Geard CR; Osmak RS; Hall EJ
Int J Radiat Oncol Biol Phys; 1985 Sep; 11(9):1653-8. PubMed ID: 3839777
[TBL] [Abstract][Full Text] [Related]
16. A metabolite of the 2-nitroimidazole misonidazole with radiosensitizing properties.
Flockhart IR; Sheldon PW; Stratford IJ; Watts ME
Int J Radiat Biol Relat Stud Phys Chem Med; 1978 Jul; 34(1):91-4. PubMed ID: 309446
[No Abstract] [Full Text] [Related]
17. Newly synthesized hypoxia-mediated drugs as radiosensitizers and cytotoxic agents.
Astor M; Hall EJ; Biaglow JE; Parham JC
Int J Radiat Oncol Biol Phys; 1982 Jan; 8(1):75-83. PubMed ID: 7061257
[TBL] [Abstract][Full Text] [Related]
18. Variation of the radiosensitizing efficiency of RSU-1069 with pre-irradiation contact times: a rapid mix study.
Austen KR; Jenner TJ; O'Neill P; Fielden EM
Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Aug; 52(2):281-8. PubMed ID: 3497125
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic transforming potential of nitroimidazole radiosensitizers.
Hall EJ; Hei TK
Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1231-4. PubMed ID: 2523882
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and metabolism of the mixed-function hypoxic cell sensitizer prototype RSU 1069 in mice.
Walton MI; Workman P
Cancer Chemother Pharmacol; 1988; 22(4):275-81. PubMed ID: 3168141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
